Wafaa Shehata-Dieler

Wafaa Shehata-Dieler

Auto-generated profile, based on publicly available information

Wafaa Shehata-Dieler

Department of Oto-Rhino-Laryngology, Head and Neck Surgery and the Comprehensive Hearing Center, University Hospital Würzburg, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2014 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
BVBarbara Vona
Barbara Vona
INIndrajit Nanda
Indrajit Nanda
CNCordula Neuner
Cordula Neuner
JSJörg Schröder
Jörg Schröder
VKVera Kalscheuer
Vera Kalscheuer
THThomas Haaf
Thomas Haaf
Terminal deletions of chromosome 4q are associated with a broad spectrum of phenotypes including cardiac, craniofacial, digital, and cognitive impairment. The rarity of this syndrome renders genotype-phenotype correlation difficult, which is further complicated by the widely different phenotypes observed in patients sharing similar deletion intervals.

15 August 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
MKMaria Köping
Maria Köping
WSWafaa Shehata-Dieler
Wafaa Shehata-Dieler
DSDieter Schneider
Dieter Schneider
MCMario Cebulla
Mario Cebulla
DODaniel Oder
Daniel Oder
SSSebastian P. Schraven
Sebastian P. Schraven
Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms like high-frequency hearing loss, tinnitus and vertigo. However, comprehensive data especially on vertigo remain scarce. The aim of this study was to examine the prevalence and characteristics of vertigo and hearing loss in patients with FD, depending on renal and cardiac parameters and get hints about the site and the pattern of the lesions. Single-center study with 57 FD patients. Every patient underwent an oto-rhino-laryngological examination as well as videonystagmography and vestibular evoked myogenic potentials (VEMPs) and audiological measurements using pure tone audiometry and auditory brainstem response audiometry (ABR). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. More than one out of three patients (35.1%) complained about hearing loss, 54.4% about vertigo and 28.1% about both symptom. In 74% a sensorineural hearing loss of at least 25 dB was found, ABR could exclude any retrocochlear lesion. Caloric testing showed abnormal values in 71.9%, VEMPs were pathological in 68%. A correlation between the side or the shape of hearing loss and pathological vestibular testing could not be revealed. Hearing loss and vertigo show a high prevalence in FD. While hearing loss seems due to a cochlear lesion, peripheral vestibular as well as central nervous pathologies cause vertigo. Thus, both the site of lesion and the pathophysiological patterns seem to differ.

14 June 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
BVBarbara Vona
Barbara Vona
MHMichaela A. H. Hofrichter
Michaela A. H. Hofrichter
JSJörg Schröder
Jörg Schröder
WSWafaa Shehata-Dieler
Wafaa Shehata-Dieler
INIndrajit Nanda
Indrajit Nanda
THThomas Haaf
Thomas Haaf
Despite recent advancements in diagnostic tools, the genomic landscape of hereditary hearing loss remains largely uncharacterized. One strategy to understand genome-wide aberrations includes the analysis of copy number variation that can be mapped using SNP-microarray technology. A growing collection of literature has begun to uncover the importance of copy number variation in hereditary hearing loss. This pilot study underpins a larger effort that involves the stage-wise analysis of hearing loss patients, many of whom have advanced to high-throughput sequencing analysis. Our data originate from the Infinium HumanOmni1-Quad v1.0 SNP-microarrays (Illumina) that provide useful markers for genome-wide association studies and copy number variation analysis. This dataset comprises a cohort of 108 individuals (99 with hearing loss, 9 normal hearing family members) for the purpose of understanding the genetic contribution of copy number variations to hereditary hearing loss. These anonymized SNP-microarray data have been uploaded to the NCBI Gene Expression Omnibus and are intended to benefit other investigators interested in aggregating platform-matched array patient datasets or as part of a supporting reference tool for other laboratories to better understand recurring copy number variations in other genetic disorders.

31 May 2017 in Speech, Language and Hearing
Verified
Journal Article
Closed access
WSWafaa Shehata-Dieler
Wafaa Shehata-Dieler
KWKathleen Wermke
Kathleen Wermke
Background: There is overwhelming evidence that auditory processing plays an important role at the beginning of language development. This contradicts long held opinion by some researchers and parents that early vocal development is innate and does not require auditory input. Consequently, vocalizations such as cooing or pre-canonical babbling do not deviate in sensory-neural hearing impaired infants. Method: Here we report twin data to contribute to this debate. Using repeated recordings of comfort utterances over the first 20 months, we objectively determined and compared the course of vocal development of a healthy identical twin pair with a profound neuro-sensory hearing disorder. Results: Recordings four weeks after CI activation demonstrated an interesting phenomenon: vocal utterances seemed to re-vitalize primitive elements, i.e., we observed an apparent vocal ‘regression’. Conclusion: The higher cognitive level of the 10-months-old girls at cochlear implantation compared to younger infants together with the more mature neural network for language development might be the essential reason for the quicker second passing of vocal stages.

2 September 2026 in Otology & Neurotology
Verified
Journal Article
Closed access
KRKristen Rak
Kristen Rak
SPStefan Plontke
Stefan Plontke
TLThomas Lenarz
Thomas Lenarz
DHDaniela Hollfelder
Daniela Hollfelder
Piotr H. SkarzynskiPiotr H. Skarzynski
Piotr H. Skarzynski
RMRobert Mlynski
Robert Mlynski
Objective: To evaluate the audiological efficacy, patient-reported outcomes, and safety of an active middle ear implant (AMEI) in children and adults with distinct coupling options. Study design: Prospective, longitudinal, multicenter, noninterventional observational study with repeated within-subject measures and a 12-month follow-up. Setting: Nine tertiary referral centers in Germany, Austria, and Poland. Patients: Adults and children with sensorineural, conductive, or mixed hearing loss. Adults were grouped by coupling method: incus long process (LP), incus short process (SP), round window (RW), or stapes head (SH); multiple couplers were used in children. Intervention: AMEI with coupler. Main outcome measures: The primary outcome was the difference in speech recognition thresholds for 50% speech recognition (SRT50) in quiet between unaided preoperative and aided 12-month postactivation. Secondary outcomes included SRT50 in noise, sound-field thresholds, patient-reported outcomes, air- and bone-conduction thresholds, and adverse events. Results: Audiological outcomes were evaluated in 67 patients. SRT50 in quiet significantly improved across all subgroups, with large effect sizes (Cohen d z >0.8): 17.9±9.3 dB (LP), 18.3±8.4 dB (SP), 25.3±6.3 dB (RW), 23.1±17.6 dB (SH), and 21.6±9.4 dB in children. SRT50 in noise improved by 4.3 to 9.2 dB, and functional gains ranged from 18.3 to 39.2 dB. Patients reported positive impacts on quality of life and perceived quality of hearing. Two device explantations and 2 revision surgeries occurred. Exploratory analyses showed no statistically detectable differences between coupling approaches. Conclusion: AMEI use was associated with significant audiological and patient‑reported improvements in adults and children. Within the limitations of this observational study, including limited power and baseline heterogeneity, no statistically detectable differences in outcomes were observed between coupling approaches. Coupler selection should therefore remain guided by anatomic and clinical considerations.